inspiremd, inc. is a company based out of 800 boylston street suite 16041, boston, massachusetts, united states.
Company profile
Ticker
NSPR
Exchange
Website
CEO
Marvin Slosman
Employees
Incorporated
Location
Fiscal year end
Industry (SIC)
Former names
Saguaro Resources, Inc.
SEC CIK
Corporate docs
IRS number
262123838
NSPR stock data
Latest filings (excl ownership)
8-K
InspireMD Announces Abstract of One-Year Follow-Up Results from the C-GUARDIANS U.S. Investigational Device Exemption (IDE) Clinical Trial Accepted for Presentation at LINC 2024
26 Mar 24
8-K
InspireMD Reports Fourth Quarter and Full-Year 2023 Financial Results and Provides Business Update
6 Mar 24
10-K
2023 FY
Annual report
5 Mar 24
8-K
InspireMD Receives CE Mark Recertification Under EU’s New Medical Device Regulation (MDR) Regulatory Framework
31 Jan 24
S-8
Registration of securities for employees
2 Jan 24
8-K
InspireMD Announces Issuance of Key U.S. Patent Covering Its SwitchGuardTM Neuroprotection System
20 Dec 23
8-K
Regulation FD Disclosure
27 Nov 23
10-Q
2023 Q3
Quarterly report
6 Nov 23
8-K
InspireMD Reports Third Quarter 2023 Financial Results and Provides
6 Nov 23
8-K
InspireMD Presents Positive 30-Day Follow-Up Results from the C-GUARDIANS
1 Nov 23
Transcripts
NSPR
Earnings call transcript
2023 Q4
6 Mar 24
NSPR
Earnings call transcript
2023 Q3
6 Nov 23
NSPR
Earnings call transcript
2023 Q2
8 Aug 23
NSPR
Earnings call transcript
2023 Q1
16 May 23
NSPR
Earnings call transcript
2022 Q4
30 Mar 23
NSPR
Earnings call transcript
2022 Q3
8 Nov 22
NSPR
Earnings call transcript
2022 Q2
9 Aug 22
NSPR
Earnings call transcript
2022 Q1
10 May 22
NSPR
Earnings call transcript
2021 Q4
8 Mar 22
NSPR
Earnings call transcript
2021 Q3
9 Nov 21
Latest ownership filings
SC 13G/A
Rosalind Advisors, Inc.
14 Feb 24
SC 13G
ORBIMED ADVISORS LLC
14 Feb 24
SC 13G
Nantahala Capital Management, LLC
14 Feb 24
4
Thomas J Kester
25 Jan 24
4
Patrick Verta
25 Jan 24
4
Shane Thomas Gleason
25 Jan 24
4
Andrea Tommasoli
25 Jan 24
4
Kathryn Arnold
25 Jan 24
4
Craig Shore
25 Jan 24
4
GARY S ROUBIN
25 Jan 24
Financial summary
Quarter (USD) | Sep 23 | Jun 23 | Mar 23 | Dec 22 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Dec 22 | Dec 21 | Dec 20 | Dec 19 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
---|---|---|---|---|---|---|
Cash on hand (at last report) | 13.84 mm | 13.84 mm | 13.84 mm | 13.84 mm | 13.84 mm | 13.84 mm |
Cash burn (monthly) | (no burn) | (no burn) | 1.88 mm | 1.69 mm | 1.35 mm | 1.28 mm |
Cash used (since last report) | n/a | n/a | 11.18 mm | 10.05 mm | 8.02 mm | 7.63 mm |
Cash remaining | n/a | n/a | 2.66 mm | 3.79 mm | 5.82 mm | 6.21 mm |
Runway (months of cash) | n/a | n/a | 1.4 | 2.2 | 4.3 | 4.8 |
Institutional ownership, Q2 2023
66.5% owned by funds/institutions
13F holders | Current |
---|---|
Total holders | 26 |
Opened positions | 14 |
Closed positions | 2 |
Increased positions | 1 |
Reduced positions | 1 |
13F shares | Current |
---|---|
Total value | 20.19 bn |
Total shares | 15.60 mm |
Total puts | 0.00 |
Total calls | 0.00 |
Total put/call ratio | – |
Largest owners | Shares | Value |
---|---|---|
Soleus Private Equity Fund III | 2.20 mm | $3.70 mm |
Orbimed Advisors | 1.86 mm | $4.67 bn |
Marshall Wace | 1.86 mm | $4.67 bn |
Marshall Wace North America | 1.86 mm | $2.70 mm |
Nantahala Capital Management | 1.86 mm | $4.67 bn |
Rosalind Advisors | 1.86 mm | $3.44 mm |
Intracoastal Capital | 1.45 mm | $494.00 k |
Soleus Capital Management | 1.38 mm | $3.46 bn |
Velan Capital Investment Management | 904.03 k | $2.27 bn |
Lind Global Macro Fund | 177.33 k | $527.00 k |
Recent insider trades
Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
23 Jan 24 | Kester Thomas J | Common Stock | Grant | Acquire A | No | No | 0 | 29,032 | 0.00 | 296,075 |
23 Jan 24 | Kester Thomas J | Options to purchase common stock Common Stock | Grant | Acquire A | No | No | 3.14 | 11,098 | 34.85 k | 70,111 |
23 Jan 24 | Patrick Verta | Common Stock | Grant | Acquire A | No | No | 0 | 85,720 | 0.00 | 228,460 |
23 Jan 24 | Patrick Verta | Options to purchase common stock Common Stock | Grant | Acquire A | No | No | 3.14 | 32,768 | 102.89 k | 79,348 |
23 Jan 24 | Shane Thomas Gleason | Common Stock | Grant | Acquire A | No | No | 0 | 238,625 | 0.00 | 514,365 |
23 Jan 24 | Shane Thomas Gleason | Options to purchase common stock Common Stock | Grant | Acquire A | No | No | 3.14 | 91,218 | 286.42 k | 183,128 |
23 Jan 24 | Andrea Tommasoli | Common Stock | Grant | Acquire A | No | No | 0 | 238,625 | 0.00 | 495,078 |
23 Jan 24 | Andrea Tommasoli | Options to purchase common stock Common Stock | Grant | Acquire A | No | No | 3.14 | 91,218 | 286.42 k | 176,699 |
23 Jan 24 | Kathryn Arnold | Common Stock | Grant | Acquire A | No | No | 0 | 29,032 | 0.00 | 215,040 |
23 Jan 24 | Kathryn Arnold | Options to purchase common stock Common Stock | Grant | Acquire A | No | No | 3.14 | 11,098 | 34.85 k | 70,109 |